Recommendations of the U.S. Public Health Service Task Force on the Use of Zidovudine to Reduce Perinatal Transmission of Human Immuno deficiency Virus

Vol. 43 / No. RR-11

MMWR

Contents
Introduction..................................................................................................... 1
Background......................................................................................................2
General Principles Regarding Treatment Recommendations.................6
Clinical Situations and Recommendations for Use of ZDV to Reduce
Perinatal Transmission............................................................................... 7
Recommendations for Monitoring the ZDV Regimen for Mothers
and Infants................................................................................................. 13
Potential Long-Term Effects of ZDV Therapy for Mothers and Infants
and Recommendations for Follow-Up......................................................14
C onclusion...................................................................................................... 15

Single copies of this document are available from the Centers for Disease Control
and Prevention, National AIDS Clearinghouse, PO. Box 6003, Rockville, MD 20850;
telephone: [phone].
Copies can be purchased from Superintendent of Documents, U.S. Government
Printing Office, Washington, DC 20402-9325; telephone: [phone].